Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by Gorf79on Aug 03, 2022 8:41am
257 Views
Post# 34867589

For all but the 28 tapped out retail holders…

For all but the 28 tapped out retail holders…... The FDA's Granting of a Breakthrough Designation is largely overlooked and long forgotten!

Sadly, few can comprehend what it portends and far fewer still know that Spectral has been granted BTD. Of course it is a massive nod to imminent FDA approval for Spectral/Baxter's PMX Sepsis therapy, yet the clueless remain so.

With Spectral being Spectral I wouldn't expect it any other way...
<< Previous
Bullboard Posts
Next >>